Monaldi Archives for Chest Disease

Scope & Guideline

Fostering Global Dialogue in Cardiology and Pulmonology

Introduction

Welcome to the Monaldi Archives for Chest Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Monaldi Archives for Chest Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1122-0643
PublisherPAGEPRESS PUBL
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 1993 to 2024
AbbreviationMONALDI ARCH CHEST D / Monaldi Arch. Chest Dis.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressMEDITGROUP, VIA G BELLI, 4, PAVIA 27100, ITALY

Aims and Scopes

The Monaldi Archives for Chest Disease focuses on advancing knowledge in pulmonary and cardiovascular medicine through diverse clinical, epidemiological, and therapeutic research. Its aim is to provide a platform for innovative studies that impact clinical practice and improve patient outcomes.
  1. Pulmonary Diseases Research:
    The journal emphasizes research on various pulmonary conditions, including tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, contributing significantly to understanding these diseases' pathophysiology, diagnosis, and management.
  2. Cardiovascular Health Studies:
    Research related to cardiovascular diseases, including heart failure, myocardial infarction, and arrhythmias, is a core area. The journal publishes studies that explore the intersection of respiratory and cardiac health, particularly in complex cases.
  3. Infectious Diseases and Public Health:
    There is a strong focus on infectious diseases, especially tuberculosis and COVID-19, reflecting the journal's commitment to addressing global health challenges and providing insights into treatment protocols and public health strategies.
  4. Innovative Therapeutic Approaches:
    The journal highlights studies on new therapeutic interventions, including pharmacological treatments, rehabilitation strategies, and innovative surgical techniques, aimed at improving patient outcomes in respiratory and cardiovascular care.
  5. Clinical and Epidemiological Studies:
    Monaldi Archives prioritizes epidemiological research that informs clinical practice, assessing risk factors, treatment outcomes, and healthcare delivery models to enhance understanding and management of chest diseases.
Recent publications have highlighted several emerging themes in the journal, reflecting current trends in chest disease research and addressing contemporary healthcare challenges.
  1. COVID-19 Impact and Management:
    The journal has seen a surge in studies focused on the effects of COVID-19 on respiratory and cardiovascular health, including post-acute sequelae, treatment strategies, and healthcare system responses, indicating a major shift in research focus due to the pandemic.
  2. Telemedicine and Remote Patient Management:
    With the rise of telehealth during the pandemic, there is an emerging trend in studies evaluating the effectiveness of telemedicine in managing chronic respiratory and cardiovascular diseases, showcasing innovative approaches to patient care.
  3. Multidisciplinary Approaches to Treatment:
    There is a growing emphasis on multidisciplinary treatment strategies that integrate various specialties, such as pulmonology, cardiology, and rehabilitation, in managing complex patients, reflecting a trend towards holistic patient care.
  4. Environmental and Socioeconomic Factors:
    Research exploring the impact of environmental factors, such as air pollution, on respiratory diseases has gained traction, highlighting the importance of understanding social determinants of health in managing chest diseases.
  5. Personalized Medicine and Biomarkers:
    There is an increasing focus on personalized medicine, including studies on biomarkers for disease prediction and treatment response, showcasing a shift towards tailored therapeutic strategies in respiratory and cardiovascular care.

Declining or Waning

While the journal continues to cover a wide range of topics, certain areas have shown a decline in publication frequency or relevance, reflecting shifting priorities in research and clinical practice.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in studies focusing solely on traditional surgical techniques for respiratory diseases, possibly due to the rise of minimally invasive and endoscopic methods that are gaining preference in clinical practice.
  2. Basic Science and Laboratory Studies:
    Research focusing on basic science aspects of pulmonary and cardiovascular diseases is less prevalent, as the journal increasingly emphasizes clinical and translational studies that directly impact patient care.
  3. Longitudinal Studies in Chronic Diseases:
    The frequency of longitudinal studies examining chronic respiratory or cardiac conditions has waned, potentially reflecting a shift towards more immediate, short-term outcome studies in the context of recent global health crises.

Similar Journals

Zeitschrift fur Pneumologie

Catalyzing Change in Pulmonary Health Research
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Egyptian Journal of Chest Diseases and Tuberculosis

Transforming knowledge into practice for better respiratory care.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0422-7638Frequency: 4 issues/year

The Egyptian Journal of Chest Diseases and Tuberculosis is a premier Open Access journal published by Wolters Kluwer Medknow Publications, focusing on the latest advancements in the fields of respiratory diseases, pulmonary medicine, and tuberculosis management. With an ISSN of 0422-7638 and an E-ISSN of 2090-9950, this journal aims to disseminate high-quality research, reviews, and clinical insights that advance the understanding and treatment of chest diseases. Since its transition to Open Access in 2018, the journal has garnered increased visibility, enabling researchers across the globe to contribute and access valuable content without barriers. Situated in India, the journal is dedicated to bridging the gap between clinical practice and research, emphasizing the significance of innovative therapeutic strategies and public health approaches in combating respiratory illnesses. We invite researchers, healthcare professionals, and students to engage with our publications as we continue to foster knowledge and foster collaboration within the global medical community.

Tuberculosis and Respiratory Diseases

Exploring the frontiers of respiratory disease management.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

Egyptian Journal of Bronchology

Advancing respiratory health through open access research.
Publisher: SPRINGERISSN: 1687-8426Frequency: 4 issues/year

Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Connecting global cardiology experts for impactful discoveries.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

LUNG

Championing excellence in respiratory research and education.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

RESPIRATION

Championing Excellence in Pulmonary Science
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Minerva Respiratory Medicine

Transforming respiratory care with cutting-edge studies.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Revista de la Federacion Argentina de Cardiologia

Innovating cardiology through research and dialogue.
Publisher: FEDERACION ARGENTINA CARDIOLOGIAISSN: 0326-646XFrequency: 4 issues/year

Revista de la Federacion Argentina de Cardiologia is a vital publication in the field of Cardiology and Cardiovascular Medicine, providing a platform for researchers and healthcare professionals to share significant findings and innovative concepts since its inception in 2012. Published by the Federacion Argentina Cardiology, this journal specifically addresses contemporary issues and advancements within cardiology, contributing to the scholarly dialogue essential for improving cardiovascular health. Despite being categorized in the Q4 quartile for 2023 and presently ranking #358 out of 387 in its field, the journal remains committed to fostering academic inquiry and disseminating valuable research for both local and global audiences. Although it is not an open-access journal, it strives to balance accessibility with rigorous academic standards, ensuring quality contributions that are critical for practitioners and students alike. The journal’s ongoing evaluation and adaptation in the ever-evolving landscape of cardiology underscore its importance in advancing cardiovascular science and practice.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Transforming critical care practices with peer-reviewed excellence.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.